Overview Financials News + Filings Key Docs Charts Ownership Insiders
|
|
Global Blood Therapeutics, Inc. (GBT)
|
|
| Operating Efficiency |
|
|
|
|
Annual |
|
| In millions, except per share items | Dec-31-21 | Dec-31-20 | Dec-31-19 | Dec-31-18 | Dec-31-17 | Dec-31-16 | Dec-31-15 | Dec-31-14 |
| | Source | Source | Source | Source | Source | Source | Source | Source |
| Turnover Ratios |
| Inventory turnover | 0.1 | 0.1 | 0.1 | | | | | |
| Asset turnover | 0.2 | 0.2 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 |
| |
| Returns on Capital |
| ROIC (excluding intangibles) | -153.4% | -79.4% | -74.0% | -78.7% | -98.8% | -165.1% | -1845.6% | -602.3% |
| ROIC (including intangibles) | -143.5% | -139.0% | -64.3% | -56.7% | -84.0% | -83.6% | -3641.2% | -546.5% |
| ROE | -146.7% | -58.4% | -48.6% | -31.9% | -37.4% | -44.6% | -33.0% | -38.8% |
| ROA | -30.7% | -33.6% | -35.3% | -29.6% | -33.4% | -41.1% | -30.5% | -36.8% |
| |
| Cash Conversion Cycle |
| Days sales outstanding | 0.0 | 0.0 | 0.0 | 0.0 | | | | |
| Days payables outstanding | 1,661.8 | 3,506.3 | 80,763.9 | 31,982.5 | | | | |
| Days inventory outstanding | 6,406.4 | 7,392.4 | 9,710.5 | | | | | |
| Cash conversion cycle | 4,744.7 | 3,886.2 | -71,053.3 | -31,982.5 | | | | |
|